Chamber and committees

Capital and resource funding for SEPA’s programme to plan, track, and deliver the regulator function for Scotland’s Deposit Return Scheme (DRS), including development and delivery of a digital producer registration service, is agreed between SEPA and the Scottish Government as part of the annual Budget process.

Once DRS goes live, the annual registration fee paid by producers with a turnover of greater than £85,000 per year will cover the cost of ongoing maintenance of the registration service and regulation of the scheme.

In December 2019 we published "Neurological Care and Support - a National Framework for Action". Over 5 years we will invest £4.5 million to implement the Framework’s 17 commitments.

Some of these commitments aim to improve access to new medicines for people living with progressive forms of MS, such as our commitment to support the neurological research agenda by promoting the work of the Chief Scientist Office, third sector organisations’ research and Scottish neurological research networks; and encouraging opportunities for people with neurological conditions to become involved in research trials.

In September 2020, the Scottish Medicines Consortium (SMC) accepted siponimod (Mayzent®) for routine use in NHS Scotland. Mayzent® is the first oral Disease Modifying Therapy (DMT) for active secondary progressive MS. The SMC Horizon Scanning Team have also identified several DMT’s in development for the treatment of progressive forms of MS which are predicted to enter the UK market within the next 5 years.

By 15 October 2021, 40,768 ventilation inspections were undertaken by local authorities across learning, teaching and play spaces.

I refer the member to the answer to question S6W-04001 on 8 November 2021. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

It is the statutory responsibility of local authorities to manage and maintain the school estate across Scotland. The Scottish Government asked local authorities to detail any ventilation mitigations or remedial action arising throughout the CO2 monitoring exercise. Areas of potentially poor ventilation should be identified by reference to the Scottish Government’s Reducing Risks in Schools Guidance, which makes clear at what level of CO2 concentration remedial action should be considered.

To date, local authorities have reported only limited instances of remedial action being required in their learning estates.

We want to ensure that wherever women seek menopause support, they get the care that they need. Menopause care is provided in different settings and in a variety of ways, in both primary and secondary care. We do not currently have the data to be able to accurately describe the variety of sources of menopause care in Scotland.

A key aim of the Women’s Health Plan is to ensure that when required women will have timely access to menopause support and services, be that though primary or specialist care.

To help achieve this we will provide access in each primary care team to a healthcare professional who has a special interest in menopause. We will also provide a specialist menopause services in every NHS Board – including a buddy system where sub specialisation is impractical.

We will be working closely with NHS Boards in order to progress these actions which will also enable us to build a comprehensive picture of the delivery of menopause care in Scotland.

Data on the number of people who have attended for menopause care in NHSScotland are not routinely available.

I refer the member to the answer to question S6W-04001 on
‎ 8 November 2021 . All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers
‎

There are no plans to undertake an immediate metastatic breast cancer audit. Our focus currently remains on maximizing available clinical capacity to see patients. Our £114.5m National Cancer Plan has a range of measures aimed at benefitting all cancer patients, including implementation of a single point of contact resource that will support patients throughout their pathway, and after discharge, including those with secondary breast cancer. We are however giving further clinical consideration to possible audit work in this area while recognising the ongoing severe pressures in our NHS.

The provisions of the National Parks (Scotland) Act 2000 enable the Scottish Ministers to make a formal proposal to establish a new National Park. We are aware that there are several areas which may be interested in obtaining National Park status. There is therefore a need to have an initial non-statutory evaluation process to determine what area or areas should be subject to a formal proposal. This evaluation process will be fair and transparent and stakeholders will be closely involved in developing it.

Further, section 3 of the Act allows the Scottish Ministers to require NatureScot, or another public body with relevant expertise, to report to Ministers on a proposal for a National Park. The reporter appointed under section 3, as part of preparing the report, must consult with every local authority and community council whose area (or part of whose area) is within the area to which the proposal relates, persons the reporter considers are representative of the interests of local residents and businesses, any other persons as the reporter thinks fit.

We are engaging HM Treasury and HMRC to ensure that VAT is not applied to deposits charged under Scotland’s Deposit Return Scheme (DRS). Any cost associated with VAT would be part of the operating costs of DRS, and would be borne by drinks producers in line with the principle of producer responsibility.